# MAP1A

## Overview
The MAP1A gene encodes the microtubule-associated protein 1A, a critical component of the neuronal cytoskeleton. This protein is part of the microtubule-associated protein family and is predominantly expressed in neurons, where it plays a vital role in stabilizing microtubules and maintaining neuronal structure and function. MAP1A is initially synthesized as a large polypeptide that undergoes proteolytic cleavage to form a heavy chain and a light chain, which together facilitate the protein's interaction with microtubules and actin filaments. These interactions are essential for the regulation of microtubule dynamics, contributing to processes such as dendritic remodeling and neuronal plasticity. The protein's function is modulated by post-translational modifications, including phosphorylation and polyglutamylation, which influence its binding affinity and activity. Dysregulation of MAP1A has been implicated in various neurological disorders, highlighting its importance in maintaining the integrity of the nervous system (Halpain2006The; Liu2015Mutations; Fink1996Human).

## Structure
The MAP1A protein is a member of the microtubule-associated protein family, primarily expressed in neurons. It is initially translated as a large polypeptide and undergoes proteolytic cleavage to produce a heavy chain (MAP1A-HC) and a light chain (LC2) (Halpain2006The). The heavy chain is approximately 350 kDa, while the light chain is 28 kDa (Halpain2006The). The human MAP1A protein consists of 2805 amino acids with a predicted molecular weight of 306.5 kDa (Fink1996Human).

MAP1A contains conserved tubulin-binding motifs in its amino-terminal region, crucial for stabilizing microtubules (Fink1996Human). The light chain can bind both microtubules and filamentous actin, with microtubule binding localized to the amino terminus and F-actin interaction to the carboxyl terminus (Halpain2006The). The protein is described as a flexible, elongated molecule, forming cross-bridges between microtubules in dendrites (Shiomura1987The).

Post-translational modifications, such as phosphorylation, affect MAP1A's binding affinity to microtubules, actin, and neurofilaments, influencing microtubule assembly (Fink1996Human). Polyglutamylation also modulates its interaction with tubulin, maintaining high affinity for highly glutamylated tubulins (Bonnet2001Differential). The exact stoichiometric composition of MAP1A heavy and light chains and specific splice variant isoforms are not fully detailed (Halpain2006The).

## Function
MAP1A (microtubule-associated protein 1A) is a critical component in the stabilization and dynamics of microtubules within neurons. It plays a significant role in maintaining the neuronal cytoskeleton, which is essential for cell shape, organelle organization, and intracellular transport. MAP1A is predominantly expressed in the adult brain, where it is found in axons and dendrites, contributing to the structural integrity and function of mature neurons (Faller2009MAP1a; Faller2008Modulation).

MAP1A interacts with microtubules to regulate their dynamic phases, such as elongation and shortening, promoting slow and stable growth crucial for maintaining and restructuring adult neurons (Faller2008Modulation). It is involved in dendritic remodeling, where it is necessary for activity-driven increases in dendritic length and branching, mediated through the activation of L-type Ca2+ channels and the MAPK pathway (Szebenyi2005ActivityDriven).

The protein also associates with light chains, such as LC2, which enhance its ability to stabilize microtubules by promoting polymerization and reducing dynamicity (Noiges2002MicrotubuleAssociated). This stabilization is vital for neuronal development and the maintenance of mature brain circuitry, highlighting MAP1A's role in neuronal plasticity and stability (Langkopf1992Microtubuleassociated; Fink1996Human).

## Clinical Significance
Mutations in the MAP1A gene have been linked to several neurological conditions, including autism spectrum disorder and schizophrenia. These mutations can lead to the degeneration of Purkinje cells, a type of neuron in the cerebellum, which is crucial for motor coordination and cognitive functions (Liu2015Mutations). The loss of MAP1A function results in the disruption of microtubule organization within neurons, leading to decreased microtubule density and altered distribution of other microtubule-associated proteins, such as MAP1B, in Purkinje cells (Liu2015Mutations). This disruption is associated with neurodegenerative defects, including tremors and ataxia, as observed in mouse models with MAP1A mutations (Liu2015Mutations).

Alterations in MAP1A expression have also been implicated in myotonic dystrophy type 1 (DM1). In cellular models of DM1, expanded CTG repeats in the DMPK gene lead to increased MAP1A levels, which are associated with impaired neurite outgrowth and altered subcellular distribution of microtubule-associated proteins (VelázquezBernardino2011Myotonic). These findings suggest that MAP1A plays a significant role in maintaining neuronal structure and function, and its dysregulation can contribute to various neurodegenerative and neuromuscular disorders.

## Interactions
MAP1A, a microtubule-associated protein, engages in various interactions with other proteins, playing a significant role in cellular structure and signaling. The light chain of MAP1A, known as LC2, interacts specifically with the GTP-bound form of the RhoB protein. This interaction is crucial for epidermal growth factor (EGF)-dependent EGF receptor signaling, with the C-terminal region of RhoB being critical for this interaction (LajoieMazenc2008MAP1A).

MAP1A also binds to actin, both in its monomeric (G-actin) and filamentous (F-actin) forms, with a stronger affinity for F-actin. This binding is dose-dependent and contributes to the crosslinking of actin filaments, which is essential for maintaining cellular morphology (Pedrotti1994Microtubule).

In the nervous system, the light chains of MAP1A interact with α1-syntrophin, specifically localizing to the PH2 and PDZ domains of α1-syntrophin. This interaction is observed in both central and peripheral nervous systems, suggesting a role in neuronal function (FuhrmannStroissnigg2012The).

MAP1A's LC2 also interacts with casein kinase 1 delta (CK1δ), where LC2 serves as a substrate for CK1δ, potentially linking phosphorylation to the regulation of microtubule dynamics (Wolff2005Interaction).


## References


[1. (Faller2009MAP1a) Elliott M. Faller, Tania S. Villeneuve, and David L. Brown. Map1a associated light chain 3 increases microtubule stability by suppressing microtubule dynamics. Molecular and Cellular Neuroscience, 41(1):85–93, May 2009. URL: http://dx.doi.org/10.1016/j.mcn.2009.02.001, doi:10.1016/j.mcn.2009.02.001. This article has 14 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.mcn.2009.02.001)

[2. (Fink1996Human) John K. Fink, Sandra M. Jones, Constance Esposito, and Jodi Wilkowski. Human microtubule-associated protein 1a (map1a) gene: genomic organization, cdna sequence, and developmental- and tissue-specific expression. Genomics, 35(3):577–585, August 1996. URL: http://dx.doi.org/10.1006/GENO.1996.0400, doi:10.1006/geno.1996.0400. This article has 36 citations and is from a peer-reviewed journal.](https://doi.org/10.1006/GENO.1996.0400)

[3. (Wolff2005Interaction) Sonja Wolff, Zhenyu Xiao, Mathias Wittau, Nadine Süssner, Martin Stöter, and Uwe Knippschild. Interaction of casein kinase 1 delta (ck1δ) with the light chain lc2 of microtubule associated protein 1a (map1a). Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1745(2):196–206, September 2005. URL: http://dx.doi.org/10.1016/j.bbamcr.2005.05.004, doi:10.1016/j.bbamcr.2005.05.004. This article has 32 citations.](https://doi.org/10.1016/j.bbamcr.2005.05.004)

[4. (Langkopf1992Microtubuleassociated) A Langkopf, J.A. Hammarback, R Müller, R.B. Vallee, and C.C. Garner. Microtubule-associated proteins 1a and lc2. two proteins encoded in one messenger rna. Journal of Biological Chemistry, 267(23):16561–16566, August 1992. URL: http://dx.doi.org/10.1016/s0021-9258(18)42039-x, doi:10.1016/s0021-9258(18)42039-x. This article has 98 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/s0021-9258(18)42039-x)

[5. (Shiomura1987The) Y Shiomura and N Hirokawa. The molecular structure of microtubule-associated protein 1a (map1a) in vivo and in vitro. an immunoelectron microscopy and quick-freeze, deep- etch study. The Journal of Neuroscience, 7(5):1461–1469, May 1987. URL: http://dx.doi.org/10.1523/jneurosci.07-05-01461.1987, doi:10.1523/jneurosci.07-05-01461.1987. This article has 58 citations.](https://doi.org/10.1523/jneurosci.07-05-01461.1987)

[6. (VelázquezBernardino2011Myotonic) Prisiliana Velázquez-Bernardino, Francisco García-Sierra, Oscar Hernández-Hernández, Mario Bermúdez de León, Geneviève Gourdon, Mário Gomes-Pereira, and Bulmaro Cisneros. Myotonic dystrophy type 1-associated ctg repeats disturb the expression and subcellular distribution of microtubule-associated proteins map1a, map2, and map6/stop in pc12 cells. Molecular Biology Reports, 39(1):415–424, May 2011. URL: http://dx.doi.org/10.1007/s11033-011-0753-y, doi:10.1007/s11033-011-0753-y. This article has 3 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s11033-011-0753-y)

[7. (Pedrotti1994Microtubule) Barbara Pedrotti, Roberto Colombo, and Khalid Islam. Microtubule associated protein map1a is an actin‐binding and crosslinking protein. Cell Motility, 29(2):110–116, January 1994. URL: http://dx.doi.org/10.1002/cm.970290203, doi:10.1002/cm.970290203. This article has 54 citations.](https://doi.org/10.1002/cm.970290203)

[8. (Szebenyi2005ActivityDriven) Györgyi Szebenyi, Flavia Bollati, Mariano Bisbal, Shelley Sheridan, Laura Faas, Robin Wray, Scott Haferkamp, Sapril Nguyen, Alfredo Caceres, and Scott T. Brady. Activity-driven dendritic remodeling requires microtubule-associated protein 1a. Current Biology, 15(20):1820–1826, October 2005. URL: http://dx.doi.org/10.1016/j.cub.2005.08.069, doi:10.1016/j.cub.2005.08.069. This article has 65 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.cub.2005.08.069)

[9. (FuhrmannStroissnigg2012The) Heike Fuhrmann-Stroissnigg, Rainer Noiges, Luise Descovich, Irmgard Fischer, Douglas E. Albrecht, Fatiha Nothias, Stanley C. Froehner, and Friedrich Propst. The light chains of microtubule-associated proteins map1a and map1b interact with α1-syntrophin in the central and peripheral nervous system. PLoS ONE, 7(11):e49722, November 2012. URL: http://dx.doi.org/10.1371/journal.pone.0049722, doi:10.1371/journal.pone.0049722. This article has 12 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0049722)

[10. (Noiges2002MicrotubuleAssociated) Rainer Noiges, René Eichinger, Waltraud Kutschera, Irmgard Fischer, Zsuzsanna Németh, Gerhard Wiche, and Friedrich Propst. Microtubule-associated protein 1a (map1a) and map1b: light chains determine distinct functional properties. The Journal of Neuroscience, 22(6):2106–2114, March 2002. URL: http://dx.doi.org/10.1523/JNEUROSCI.22-06-02106.2002, doi:10.1523/jneurosci.22-06-02106.2002. This article has 126 citations.](https://doi.org/10.1523/JNEUROSCI.22-06-02106.2002)

[11. (Halpain2006The) Shelley Halpain and Leif Dehmelt. The map1 family of microtubule-associated proteins. Genome Biology, 7(6):224, 2006. URL: http://dx.doi.org/10.1186/gb-2006-7-6-224, doi:10.1186/gb-2006-7-6-224. This article has 205 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1186/gb-2006-7-6-224)

[12. (Liu2015Mutations) Ye Liu, Jeong Woong Lee, and Susan L. Ackerman. Mutations in the microtubule-associated protein 1a (map1a) gene cause purkinje cell degeneration. The Journal of Neuroscience, 35(11):4587–4598, March 2015. URL: http://dx.doi.org/10.1523/JNEUROSCI.2757-14.2015, doi:10.1523/jneurosci.2757-14.2015. This article has 58 citations.](https://doi.org/10.1523/JNEUROSCI.2757-14.2015)

[13. (Faller2008Modulation) Elliott M. Faller and David L. Brown. Modulation of microtubule dynamics by the microtubule‐associated protein 1a. Journal of Neuroscience Research, 87(5):1080–1089, October 2008. URL: http://dx.doi.org/10.1002/jnr.21920, doi:10.1002/jnr.21920. This article has 9 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/jnr.21920)

[14. (Bonnet2001Differential) Crystel Bonnet, Dominique Boucher, Sylvie Lazereg, Barbara Pedrotti, Khalid Islam, Philippe Denoulet, and Jean Christophe Larcher. Differential binding regulation of microtubule-associated proteins map1a, map1b, and map2 by tubulin polyglutamylation. Journal of Biological Chemistry, 276(16):12839–12848, April 2001. URL: http://dx.doi.org/10.1074/JBC.M011380200, doi:10.1074/jbc.m011380200. This article has 275 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/JBC.M011380200)

[15. (LajoieMazenc2008MAP1A) Isabelle Lajoie-Mazenc, Daniel Tovar, Marie Penary, Barbara Lortal, Sophie Allart, Cyril Favard, Meryem Brihoum, Anne Pradines, and Gilles Favre. Map1a light chain-2 interacts with gtp-rhob to control epidermal growth factor (egf)-dependent egf receptor signaling. Journal of Biological Chemistry, 283(7):4155–4164, February 2008. URL: http://dx.doi.org/10.1074/jbc.M709639200, doi:10.1074/jbc.m709639200. This article has 38 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.M709639200)